Medtronic (MDT +0.3%) says it's successfully completed the first phase of feasibility studies on...
Wednesday, October 3, 2012, 2:12 PM ETMedtronic (MDT +0.3%) says it's successfully completed the first phase of feasibility studies on its next-generation renal denervation system, which features a simultaneously firing multi-electrode catheter and advanced radio-frequency generator. A total of nine patients were treated with a 100% acute success rate in accessing the vessels and delivering therapy. The system is only in its investigational phase however, and isn't yet commercially available anywhere in the world.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles